financetom
Business
financetom
/
Business
/
Sphere Entertainment Shares Rise After Reporting Q1 Net Loss Widens
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sphere Entertainment Shares Rise After Reporting Q1 Net Loss Widens
May 26, 2025 4:12 AM

10:12 AM EDT, 05/08/2025 (MT Newswires) -- Sphere Entertainment ( SPHR ) shares were up 2% in recent Thursday trading after reporting its Q1 net loss widened.

The company reported a Q1 net loss Thursday of $2.27 per diluted share, wider than a loss of $1.33 a year earlier.

Analysts polled by FactSet expected a net loss of $2.18.

Revenue for the quarter ended March 31 was $280.6 million, down from $321.3 million a year earlier.

Analysts surveyed by FactSet expected $289.6 million.

Price: 29.84, Change: +0.05, Percent Change: +0.18

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Oil Rig Count Rises by Three This Week as Crude Heads For First Weekly Gain in Five Weeks
Oil Rig Count Rises by Three This Week as Crude Heads For First Weekly Gain in Five Weeks
Aug 9, 2024
03:29 PM EDT, 08/09/2024 (MT Newswires) -- The number of oil rigs in the US rose by three for the week ended Friday, according to data compiled by energy services company Baker Hughes ( BKR ) . The count for oil increased to 485 from 482 on a weekly basis. The tally for gas fell by one to 97, while...
Merck's $1.3B Deal For Potential Autoimmune Disorder Candidate Is Relevant To Cullinan's Investigational Drug, Says Analyst
Merck's $1.3B Deal For Potential Autoimmune Disorder Candidate Is Relevant To Cullinan's Investigational Drug, Says Analyst
Aug 9, 2024
On Friday, Merck & Co Inc ( MRK ) agreed to acquire CN201, an investigational clinical-stage bispecific antibody for B-cell-associated diseases, from privately-held Curon Biopharmaceutical. “We continue to identify opportunities to expand and diversify our pipeline,” said Dr. Dean Y. Li, president of Merck Research Laboratories. “Early clinical data have provided robust evidence for the potential of CN201 to target and...
Update: Stellantis Notifies Union of Thousands of Potential Job Cuts at Detroit Plant
Update: Stellantis Notifies Union of Thousands of Potential Job Cuts at Detroit Plant
Aug 9, 2024
03:17 PM EDT, 08/09/2024 (MT Newswires) -- (Updates with additional details and attempts to reach out to the union.) Stellantis ( STLA ) has notified concerned parties, including union members that it could lay off as many as 2,450 of the 3,700 workers at its plant in Warren, Michigan, a company spokesperson confirmed to MT Newswires. However, the company expects...
--Ameren Maintains Quarterly Dividend at $0.67 per Share, Payable Sept. 30 to Shareholders of Record Sept. 11
--Ameren Maintains Quarterly Dividend at $0.67 per Share, Payable Sept. 30 to Shareholders of Record Sept. 11
Aug 9, 2024
01:46 PM EDT, 08/09/2024 (MT Newswires) -- Price: 80.32, Change: +0.12, Percent Change: +0.15 ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved